Maternal Obesity and Pre-Pregnancy Folic Acid Supplementation

Files in This Item:
File Description SizeFormat 
Maternal obesity and pre-pregnancy folic acid supplementation.pdf564.75 kBAdobe PDFDownload
Title: Maternal Obesity and Pre-Pregnancy Folic Acid Supplementation
Authors: Farah, Nadine
Kennedy, Cormac
Turner, Ciara
O'Dwyer, Vicky
Kennelly, Mairead M.
Turner, Michael J.
Permanent link:
Date: 24-Apr-2013
Online since: 2019-04-30T12:10:53Z
Abstract: Objective: The purpose of this nested cohort study was to compare the rate of pre-pregnancy supplementation in obese women with that of women with a normal BMI. Methods: Pregnant women were enrolled at their convenience in a large university hospital. Weight and height were measured in the first trimester and BMI categorised. Results: Of the 288 women, 35.1% were in the normal, 29.5% in the overweight and 35.4% in the obese BMI categories. Only 45.1% (n = 46) of the obese women took pre-pregnancy folic acid compared with 60.4% (n = 61) of women with a normal BMI (p < 0.03). The lower incidence of folic acid supplementation in obese women was associated with an unplanned pregnancy in 36.3% of women compared with 22.8% in the normal BMI category (p < 0.04). Conclusions: Obese women should take folate supplements whether they are planning to conceive or not.
Type of material: Journal Article
Publisher: Karger
Journal: Obesity Facts
Volume: 6
Start page: 211
End page: 215
Keywords: Maternal obesityPre-pregnancy folic acidBody mass indexUnplanned pregnancy
DOI: 10.1159/000350393
Language: en
Status of Item: Peer reviewed
Appears in Collections:Medicine Research Collection

Show full item record

Citations 20

Last Week
Last month
checked on May 17, 2019

Google ScholarTM



This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.